1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Canopy Growth Corporation

Canopy Growth Corporation

WEED.TO
Canopy Growth CorporationCA flagToronto Stock Exchange
1.34
CAD
-0.05
- -
243.53MMarket Cap
Canopy Growth Corporation
WEED.TO
(Toronto Stock Exchange)

Recent

price

1.34

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2013
2014
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.02
- -
0.05
0.04
- -
0.38
1.65
3.35
4.4
8.48
11.46
14.71
12.16
7.19
3.97
2.5
1.03
Revenue per Share
-0.84
-0.24
-0.21
-0.64
-157.72
-2.98
-0.45
-0.63
-3.79
-27.58
-37.96
-46.95
-7.92
-70.69
-8.79
-5.56
-1.21
Basic EPS, GAAP
-0.22
-0.28
-0.19
-0.37
-411.28
-7.25
-3.34
-4.76
-14.64
-46.96
-42.94
-17.22
-15.18
-12.25
-3.82
-1.65
-0.32
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.84
-0.51
4.99
4.33
- -
6.64
15.23
50.45
55.57
194.54
58.91
29.61
28.23
-37.4
-27.89
-19.82
-6.92
Book Value per Share
18.13
5.57
5.36
4.96
- -
7.22
9.23
19.84
46.63
188.17
78.93
38.32
38.36
11.08
4.72
3.29
2.36
Tangible Book Value per Share
- -
- -
- -
- -
- -
3
8
12
18
27
35
37
39
46
75
108
269
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
1
13
40
78
226
399
547
476
333
297
269
278
Sales/Revenue/Turnover
-4,903.1
- -
-449.15
-1,559.07
- -
-675.34
-10.38
-16.83
-149.06
-271.3
-257
-107.21
-134.22
-118.76
-43.06
-24.68
-17.97
Operating Margin (%)
- -
- -
- -
- -
- -
- -
2
6
20
47
125
127
111
80
53
43
39
Depreciation Expense
- -
- -
- -
- -
-1
-9
-3
-8
-67
-736
-1,321
-1,745
-310
-3,278
-657
-598
-327
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-4,903.1
- -
-449.15
-1,559.07
- -
-779.58
-27.53
-18.85
-86.32
-325.3
-331.35
-319.2
-65.18
-983.68
-221.19
-222.35
-117.31
Profit Margin (%)
1
1
1
- -
- -
8
38
161
390
4,507
2,144
2,554
1,514
273
136
200
426
Working Capital
- -
- -
- -
- -
- -
2
3
9
7
842
569
1,667
1,593
828
549
328
242
LT Debt
1
1
1
- -
- -
22
124
640
1,243
7,072
5,178
3,622
3,620
760
501
487
758
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
-13.86
-429.92
-89.79
-5.1
-2.1
-8.49
-23.83
-36.48
-110.76
-28.12
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'26
Sep'26
Dec'26
ST Debt
19
14
13
LT Borrowings
289
226
225
LT Finance Leases
20
19
17
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
205
332
368
Market Capitalization
216
387
420

Working Capital

FRC

•

in mil. unless spec.
Jun'26
Sep'26
Dec'26
Total Current Assets
303
446
525
Cash, Cash Equivalents & STI
144
298
371
Accounts Receivable, Net
48
25
29
Inventories
94
102
106
Total Current Liabilities
99
81
98
Payables & Accruals
44
37
41
ST Debt
19
14
13
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
127.86%
-29.18%
-2.66%
Free Cash Flow
74.28%
-31.3%
-38.09%
Net Income, GAAP
274.08%
163.64%
-9%
Sales/Revenue/Turnover
155.84%
-5.23%
-9.47%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
76
70
79
73
297
2025
66
63
75
65
269
2026
72
67
75
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.69
-4.33
-2.61
- -
-8.79
2025
-1.6
-1.48
-1.11
- -
-5.56
2026
-0.22
-0.01
-0.18
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Vivesto AB (VIVE.ST)
Pure Global Cannabis Inc. (PRCNF)
Diurnal Group plc (DNL.L)
Celadon Pharmaceuticals Plc (CEL.L)
Yooma Wellness Inc. (LVVEF)
Taisho Pharmaceutical Holdings Co., Ltd. (4581.T)
Business
Canopy Growth Corporation engages in the production, distribution and sale of cannabis, hemp and cannabis-related products for recreational, medical and wellness purposes. The company offers a diverse portfolio of cannabis products including dried flower, oils, soft-gel capsules, edibles, vapes, beverages and accessories through owned and licensed brands such as Tweed, 7ACRES, DOJA, Deep Space, Claybourne, Tokyo Smoke, Spectrum Therapeutics and First & Free; it also provides vaporization devices via Storz & Bickel and lifestyle CBD products via This Works. Canopy Growth operates through segments encompassing Canada Cannabis, International Markets Cannabis, Storz & Bickel and This Works, with principal activities in Canada, Germany, Australia, Europe and a comprehensive U.S. ecosystem via Canopy USA, LLC. Founded in 2013 and headquartered in Smiths Falls, Ontario, Canada, the company maintains global operations and targets adult-use consumers, medical patients and wellness customers. In recent developments, Canopy Growth completed the acquisition of Acreage Holdings, Inc. through Canopy USA in May 2025, establishing a vertically integrated multi-state operator in the U.S. Midwest and Northeast; it finalized 100% ownership of Wana Wellness, LLC (including The CIMA Group and Mountain High Products), a leading North American edibles brand, and approximately 77% of Lemurian Inc. (Jetty Extracts), a California-based vape and extracts producer, in 2024. The company established a new US$200 million at-the-market equity program in August 2025 to fund investments, potential acquisitions, working capital and debt repayment, replacing a prior program from February 2025. Canopy Growth continues international expansion in Germany and Poland while advancing U.S. THC market opportunities independent of federal legalization, alongside ongoing product innovations like VEAZY beverages.

Company News

MCPAPIChat

  • proactiveinvestors.com

    Canopy Growth revenue climbs 14% in Q4

  • gurufocus.com

    Canopy Growth Announces Claybourne's Frosted Flyers Wins 'Best Infused Pre-Roll' at 2026 Grow Up Awards

  • gurufocus.com

    Canopy Growth Relaunches Tweed Brand in Germany with New MTL Cannabis Strain Lineup, Marking First International Release following Acquisition

  • proactiveinvestors.com

    Canopy Growth posts mixed Q3 results, narrower loss amid ongoing cost cuts

  • globenewswire.com

    2026 Asset Growth: Why Federal Compliance Is the New Metric

  • globenewswire.com

    The "New Vice" Economy: 5 Stocks Profiting from the Shift to Clean Fuel

  • proactiveinvestors.com

    Canopy Growth to acquire MTL Cannabis, expanding Québec presence